Reaction of deoxy-Hb with the periodate-oxidized derivatives of nicotinamide adenine dinucleotide (o-NAD), phosphoribosyl pyrophosphate (o-PRPP), adenosine triphosphate (o-ATP), glucose-1-phosphate (o-glc-1-P) and nicotinamide adenine dinucleotide phosphate (o-NADP) led to formation of cross-link adducts in varying yields as determined by SDS-polyacrylamide gel electrophoresis. Oxygen equilibrium studies were performed on Hb’s cross-linked with o-NAD, o-PRPP and o-ATP. These derivatives were found to have increased oxygen affinity and were cross-linked between the β chains. Inositol hexaphosphate (IHP) blocked modification by these reagents, suggesting that modification was occurring in the organic phosphate binding site. In addition, it was found that the bifunctional reagent 4,4’-diisothiocyanatostilbene-2,2’-disulfo-nate (DIDS) also led to formation of Hb cross-linked between the β chains, but resulted in a derivative with a dramatically decreased oxygen affinity, properties making it a potential candidate as an Hb-based cell-free blood substitute

Keywords:
Blood substitute, Chemical modification, Hemoglobin
This content is only available via PDF.
© 1987 S. Karger AG, Basel
1987
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.